Vera Therapeutics Inc is a clinical stage biotechnology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
VERA is expected to report earnings to fall 6.51% to -158 cents per share on August 06
Q2'26
Est.
$-1.58
Q1'26
Missed
by $0.36
Q4'25
Missed
by $0.11
Q3'25
Missed
by $0.11
Q2'25
Missed
by $0.38
The last earnings report on May 07 showed earnings per share of -169 cents, missing the estimate of -133 cents. With 784.52K shares outstanding, the current market capitalization sits at 2.30B.